← Leaderboards

Richard S. Legro

Pennsylvania State Univ Hershey Med Ctr

Google Scholar ↗PubMed ↗ORCID ↗

$15,817,930

Attributed

$17,401,233

Total exposure

60

Grants

41

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2005–25

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$17,401,233 · 60

By mechanism

R01$6,153,782 · 3

U10$4,960,703 · 1

M01$2,247,791 · 50

UH3$1,745,362 · 1

UG3$1,421,244 · 1

K24$675,135 · 1

Top collaborators

Ian M Paul4 shared

Most similar at Pennsylvania State Univ Hershey Med Ctr

Same institution · by research overlap

Robert Cooney$102,133

Others in their field

Top investigators on “Polycystic Ovary Syndrome”

Andrea Dunaif · Brigham And Women'S Hospital$16,292,187
Sally Radovick · Children'S Hospital Boston$8,337,239
David A Ehrmann · University Of Chicago$7,320,294
Kelle H Moley · Washington University$7,019,757
R Jeffrey Chang · University Of California San Diego$6,992,038
Valerie C. Montgomery-Rice · Meharry Medical College$6,875,000

Research focus

Polycystic Ovary SyndromeFemaleWomanResearch PersonnelUnited States National Institutes Of HealthClinical ResearchFundingGrantAffectHyperandrogenismPhenotypeSyndromePregnancyInsulin ResistanceComputer Retrieval Of Information On Scientific Projects DatabaseSourceInstitutionResourcesAnovulationReproductiveHuman SubjectInfertilityObesityMetformin

Grant awards (113)

Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia$866,500

UH3 · FY2025 · HL

Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia$878,862

UH3 · FY2024 · HL

Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)$403,288

R01 · FY2024 · AT · contact PI

Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia$757,651

UG3 · FY2023 · HL

Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia$663,593

UG3 · FY2022 · HL

Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)$527,034

R01 · FY2022 · AT · contact PI

Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)$527,033

R01 · FY2021 · AT · contact PI

Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)$527,035

R01 · FY2019 · AT · contact PI

Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)$539,301

R01 · FY2018 · AT · contact PI

A RCT of preconception weight loss vs. OCP in overweight infertile PCOS women$361,434

U10 · FY2017 · HD · contact PI

A RCT of preconception weight loss vs. OCP in overweight infertile PCOS women$367,553

U10 · FY2016 · HD · contact PI

A RCT of preconception weight loss vs. OCP in overweight infertile PCOS women$90,000

U10 · FY2016 · HD · contact PI

A RCT of preconception weight loss vs. OCP in overweight infertile PCOS women$386,924

U10 · FY2015 · HD · contact PI

Annual Meeting of the Androgen Excess Society$6,000

R13 · FY2015 · HD · contact PI

A RCT of preconception weight loss vs. OCP in overweight infertile PCOS women$295,134

U10 · FY2014 · HD · contact PI

Annual Meeting of the Androgen Excess Society$6,000

R13 · FY2014 · HD · contact PI

A RCT of preconception weight loss vs. OCP in overweight infertile PCOS women$317,316

U10 · FY2013 · HD · contact PI

Annual Meeting of the Androgen Excess Society$6,000

R13 · FY2013 · HD · contact PI

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women$623,042

R01 · FY2012 · HD · contact PI

A Randomized Trial of Letrozole vs Clomiphene in Infertile Women with PCOS$222,924

U10 · FY2012 · HD · contact PI

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women$629,768

R01 · FY2011 · HD · contact PI

A Randomized Trial of Letrozole vs Clomiphene in Infertile Women with PCOS$284,211

U10 · FY2011 · HD · contact PI

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women$625,180

R01 · FY2010 · HD · contact PI

A Randomized Trial of Letrozole vs Clomiphene in Infertile Women with PCOS$293,000

U10 · FY2010 · HD · contact PI

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women$626,528

R01 · FY2009 · HD · contact PI

A Randomized Trial of Letrozole vs Clomiphene in Infertile Women with PCOS$295,960

U10 · FY2009 · HD · contact PI

A Randomized Trial of Letrozole vs Clomiphene in Infertile Women with PCOS$274,042

U10 · FY2009 · HD · contact PI

PHENOTYPING KINDREDS OF FAMILIAL PCOS$79,039

M01 · FY2009 · RR · contact PI

TREATMENT OF HYPERANDROGENISM VS INSULIN RESISTANCE IN INFERTILE PCOS WOMEN$57,778

M01 · FY2009 · RR · contact PI

24HR BLOOD PRESSURE MONITORING IN PATIENTS AT RISK FOR HYPERTENSION IN PREGNANCY$51,306

M01 · FY2009 · RR · contact PI

GENOTYPING FAMILIES OF WOMEN WITH PCOS$37,901

M01 · FY2009 · RR · contact PI

PREGNANCY IN POLYCYSTIC OVARY SYNDROME II$11,555

M01 · FY2009 · RR · contact PI

DEVELOPMENT OF A SCREENING TEST FOR ENDOMETRIAL HYPERPLASIA IN AN AT RISK COHORT$7,395

M01 · FY2009 · RR · contact PI

ATORVASTATIN FOR TREATMENT OF PCOS WOMEN WITH ELEVATED LDL CHOLESTEROL$6,471

M01 · FY2009 · RR · contact PI

CONTINUOUS GLUCOSE MONITORING IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME$6,471

M01 · FY2009 · RR · contact PI

HYPERANDROGENISM AND INSULIN RESISTANCE IN THE ONTOGENY OF PCOS$2,773

M01 · FY2009 · RR · contact PI

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women$618,648

R01 · FY2008 · HD · contact PI

A Randomized Trial of Letrozole vs Clomiphene in Infertile Women with PCOS$295,960

U10 · FY2008 · HD · contact PI

EFFECT OF LIFESTYLE INTERVENTION & METFORMIN IN POLYCYSTIC OVARY SYNDROME$119,681

M01 · FY2008 · RR · contact PI

ATORVASTATIN FOR TREATMENT OF PCOS WOMEN WITH ELEVATED LDL CHOLESTEROL$58,826

M01 · FY2008 · RR · contact PI

CONTINUOUS GLUCOSE MONITORING IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME$41,787

M01 · FY2008 · RR · contact PI

The treatment of dysmenorrhea: Effects of sildenafil and oral contraceptives$30,342

R03 · FY2008 · TW · contact PI

24HR BLOOD PRESSURE MONITORING IN PATIENTS AT RISK FOR HYPERTENSION IN PREGNANCY$24,342

M01 · FY2008 · RR · contact PI

RACIAL DIFFERENCES IN CIRCULATING SEX STEROIDS: MECHANISMS AND EFFECT ON BONE$21,096

M01 · FY2008 · RR · contact PI

DEVELOPMENT OF A SCREENING TEST FOR ENDOMETRIAL HYPERPLASIA IN AN AT RISK COHORT$5,274

M01 · FY2008 · RR · contact PI

GENOTYPING FAMILIES OF WOMEN WITH PCOS$4,057

M01 · FY2008 · RR · contact PI

PHENOTYPING KINDREDS OF FAMILIAL PCOS$3,246

M01 · FY2008 · RR · contact PI

A Randomized Trial of Letrozole vs Clomiphene in Infertile Women with PCOS$302,000

U10 · FY2007 · HD · contact PI

EFFECT OF LIFESTYLE INTERVENTION & METFORMIN IN POLYCYSTIC OVARY SYNDROME$68,612

M01 · FY2007 · RR · contact PI

The treatment of dysmenorrhea: Effects of sildenafil and oral contraceptives$30,342

R03 · FY2007 · TW · contact PI

PHENOTYPING KINDREDS OF FAMILIAL PCOS$27,953

M01 · FY2007 · RR · contact PI

GENOTYPING FAMILIES OF WOMEN WITH PCOS$23,960

M01 · FY2007 · RR · contact PI

CONTINUOUS GLUCOSE MONITORING IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME$23,960

M01 · FY2007 · RR · contact PI

MEALS OF VARYING FAT & FIBER CONTENT EFFECT ON POSTPRANDIAL TESTOSTERONE CONC$21,055

M01 · FY2007 · RR · contact PI

DEVELOPMENT OF A SCREENING TEST FOR ENDOMETRIAL HYPERPLASIA IN AN AT RISK COHORT$8,350

M01 · FY2007 · RR · contact PI

RACIAL DIFFERENCES IN CIRCULATING SEX STEROIDS: MECHANISMS AND EFFECT ON BONE$7,986

M01 · FY2007 · RR · contact PI

ATORVASTATIN FOR TREATMENT OF PCOS WOMEN WITH ELEVATED LDL CHOLESTEROL$6,897

M01 · FY2007 · RR · contact PI

PHENOTYPING KINDREDS OF FAMILIAL PCOS$4,356

M01 · FY2007 · RR · contact PI

EFFECT OF MEALS OF VARYING FAT & FIBER CONTENT ON POSTPRANDIAL TESTOSTERONE$1,452

M01 · FY2007 · RR · contact PI

INSULIN RESISTANCE MARKERS IN CHILDREN$726

M01 · FY2007 · RR · contact PI

EFFECT OF LIFESTYLE INTERVENTION & METFORMIN IN POLYCYSTIC OVARY SYNDROME$118,722

M01 · FY2006 · RR · contact PI

RACIAL DIFFERENCES IN CIRCULATING SEX STEROIDS: MECHANISMS AND EFFECT ON BONE$92,483

M01 · FY2006 · RR · contact PI

PHENOTYPING KINDREDS OF FAMILIAL PCOS$85,170

M01 · FY2006 · RR · contact PI

GENOTYPING FAMILIES OF WOMEN WITH PCOS$64,953

M01 · FY2006 · RR · contact PI

The treatment of dysmenorrhea: Effects of sildenafil and oral contraceptives$37,748

R03 · FY2006 · TW · contact PI

EFFECTS OF CONTINUOUS ADMIN OF A MONOPHASIC ORAL CONTRACEPTIVE ON BLEEDING DAYS$36,563

M01 · FY2006 · RR · contact PI

CONTINUOUS GLUCOSE MONITORING IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME$23,658

M01 · FY2006 · RR · contact PI

EFFECTS OF MEALS OF VARYING FAT&FIBER CONTENT ON POSTPRANDIAL TESTOSTERONE CONC$9,463

M01 · FY2006 · RR · contact PI

TRIAL OF CLOMIPHENE CITRATE, METFORMIN & COMBINED CLOM/METF IN INFERTILITY PCOS$7,743

M01 · FY2006 · RR · contact PI

EFFECT OF MEALS OF VARYING FAT & FIBER CONTENT ON POSTPRANDIAL TESTOSTERONE$7,313

M01 · FY2006 · RR · contact PI

PHENOTYPING KINDREDS OF FAMILIAL PCOS$3,011

M01 · FY2006 · RR · contact PI

TRIAL OF CLOMIPHENE CITRATE, METFORMIN &COMBINED CLOM/METF IN INFERTILITY PCOS$209,735

M01 · FY2005 · RR

INSULIN RESISTANCE IN PCOS--SEQUELAE AND TREATMENT$135,027

K24 · FY2005 · HD

PHENOTYPING KINDREDS OF FAMILIAL PCOS$130,192

M01 · FY2005 · RR

EFFECTS OF CONTINUOUS ADMIN OF A MONOPHASIC ORAL CONTRACEPTIVE ON BLEEDING DAYS$119,654

M01 · FY2005 · RR

GENOTYPING FAMILIES OF WOMEN WITH PCOS$84,981

M01 · FY2005 · RR

EFFECT OF LIFESTYLE INTERVENTION &METFORMIN IN POLYCYSTIC OVARY SYNDROME$39,771

M01 · FY2005 · RR

RACIAL DIFFERENCES IN CIRCULATING SEX STEROIDS: MECHANISMS AND EFFECT ON BONE$26,514

M01 · FY2005 · RR

CONTINUOUS GLUCOSE MONITORING IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME$680

M01 · FY2005 · RR

COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORK$196,191

U10 · FY2004 · HD

Effect of Continuous vs. Sequential Oral Contraception$168,975

R01 · FY2004 · HD

INSULIN RESISTANCE IN PCOS--SEQUELAE AND TREATMENT$135,027

K24 · FY2004 · HD

Trial of Clomiphene citrate/metformin in PCOS Infertilit$126,527

M01 · FY2004 · RR

Phenotyping Kindreds of Familial PCOS$125,654

M01 · FY2004 · RR

Genotyping Families of Women with PCOS$109,075

M01 · FY2004 · RR

Insulin Resistance Markers in Children$46,830

M01 · FY2004 · RR

Continuous dose of oral contracetive on bleeding days$39,849

M01 · FY2004 · RR

Atorvastatin treatment of PCOS women with LDL/cholestero$4,945

M01 · FY2004 · RR

COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORK$284,535

U10 · FY2003 · HD

Effect of Continuous vs. Sequential Oral Contraception$168,975

R01 · FY2003 · HD

INSULIN RESISTANCE IN PCOS--SEQUELAE AND TREATMENT$135,027

K24 · FY2003 · HD

COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORK$254,336

U10 · FY2002 · HD

Effect of Continuous vs. Sequential Oral Contraception$168,975

R01 · FY2002 · HD

INSULIN RESISTANCE IN PCOS--SEQUELAE AND TREATMENT$135,027

K24 · FY2002 · HD

PHENOTYPING KINDRIDS OF FAMILIAL POLYCYSTIC OVARY SYNDROME$0

M01 · FY2002 · RR

EXERCISE ON INSULIN TOLERANCE IN WOMEN WITH PCOS$0

M01 · FY2002 · RR

PHENOTYPE AND GENOTYPE IN FAMILIAL POLYCYSTIC OVARY SYNDROME$0

M01 · FY2002 · RR

ASSESSING SAFETY/EFFICACY OF TROGLITAZONE IN PCOS--POLYCYSTIC OVARY SYNDROME$0

M01 · FY2002 · RR

GENOTYPING FAMILIES OF WOMEN WITH PCOS--POLYCYSTIC OVARY SYNDROME$0

M01 · FY2002 · RR

COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORK$251,091

U10 · FY2001 · HD

INSULIN RESISTANCE IN PCOS--SEQUELAE AND TREATMENT$135,027

K24 · FY2001 · HD

PHENOTYPE AND GENOTYPE IN FAMILIAL POLYCYSTIC OVARY SYNDROME$0

M01 · FY2001 · RR

GENOTYPING FAMILIES OF WOMEN WITH PCOS--POLYCYSTIC OVARY SYNDROME$0

M01 · FY2001 · RR

PHENOTYPING KINDRIDS OF FAMILIAL POLYCYSTIC OVARY SYNDROME$0

M01 · FY2001 · RR

ASSESSING SAFETY/EFFICACY OF TROGLITAZONE IN PCOS--POLYCYSTIC OVARY SYNDROME$0

M01 · FY2001 · RR

EXERCISE ON INSULIN TOLERANCE IN WOMEN WITH PCOS$0

M01 · FY2001 · RR

COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORK$188,092

U10 · FY2000 · HD

GENETICS OF FAMILIAL POLYCYSTIC OVARY SYNDROME$80,784

K08 · FY2000 · HD

EXERCISE ON INSULIN TOLERANCE IN WOMEN WITH PCOS$0

M01 · FY2000 · RR

PHENOTYPE AND GENOTYPE IN FAMILIAL POLYCYSTIC OVARY SYNDROME$0

M01 · FY2000 · RR

ASSESSING SAFETY/EFFICACY OF TROGLITAZONE IN PCOS--POLYCYSTIC OVARY SYNDROME$0

M01 · FY2000 · RR

GENOTYPING FAMILIES OF WOMEN WITH PCOS--POLYCYSTIC OVARY SYNDROME$0

M01 · FY2000 · RR

PHENOTYPING KINDRIDS OF FAMILIAL POLYCYSTIC OVARY SYNDROME$0

M01 · FY2000 · RR